Wildy logo
(020) 7242 5778
enquiries@wildy.com

Wildy’s Book News

Book News cover photo

Vol 23 No 4 April/May 2018

Book of the Month

Cover of Williams, Mortimer and Sunnucks: Executors, Administrators and Probate

Williams, Mortimer and Sunnucks: Executors, Administrators and Probate

Edited by: Alexander Learmonth, Charlotte Ford, Julia Clark, John Ross Martyn
Price: £295.00

Offers for Newly Called Barristers & Students

Special Discounts for Newly Called & Students

Read More ...


Secondhand & Out of Print

Browse Secondhand Online

Read More...


Lowe legislation jp
Sealy millman 2018 jp
Desmith out now
Uk supremem 1 8
Williams published
Luba housing

UK Public Holiday Monday 28th May

Wildy's will be closed on Monday 28th May, re-opening on Tuesday 29th.

Online book orders received during the time we are closed will be processed as soon as possible once we re-open on Tuesday.

As usual credit cards will not be charged until the order is processed and ready to despatch.

Any Sweet & Maxwell or Lexis eBook orders placed after 4pm on the Friday 25th May will not be processed until Tuesday May 29th. UK orders for other publishers will be processed as normal. All non-UK eBook orders will be processed on Tuesday May 29th.

Hide this message

This book is now Out of Print.
A new edition has been published, the details can be seen here:
Pharmaceuticals, Biotechnology and the Law 3rd ed isbn 9781405781664

Pharmaceuticals, Biotechnology and the Law 2nd ed


ISBN13: 9780406914415
New Edition ISBN: 9781405781664
Published: January 2009
Publisher: LexisNexis Butterworths
Country of Publication: UK
Format: Hardback
Price: Out of print



Wildy's Book of the Month - February 2009

Pharmaceuticals Biotechnology and the Law is the definitive guide to the law in Europe relating to pharmaceuticals, biotechnology and their related areas such as medical devices.

Written by one of the country's leading patent and regulatory lawyers, this is the only text which comprehensively covers the wide variety of legal and regulatory issues which surround these industry sectors.

The book examines the background to, and the impact of, the law affecting this area. The text is primarily written from the perspective of European Community law, although in those relatively few areas where this is not harmonised it is written from the perspective of English law.

Subjects:
Intellectual Property Law, Medical Law
Contents:
Introduction and Overview;
Drug discovery and industry overview;
Intellectual property overview;
Regulatory overview;
Competition law overview;
Early stage R&D;
Regulatory issues associated with early stage pharmaceuticals R&D, including ethical issues associated with stem cells, and animal experimentation;
Special regulatory issues associated with biotechnology, including contained use and deliberate release;
Patents issues associated with early stage pharmaceuticals R&D;
Patents issues associated with biotechnology;
Agreements in early stage R&D;
Late stage R&D;
Regulatory issues associated with pharmaceuticals, including clinical trials;
Regulatory issues associated with late stage R&D in other applications of biotechnology than pharmaceuticals;
Regulatory issues associated with late stage R&D in other life sciences sectors;
Patents issues associated with late stage pharmaceuticals R&D
Agreements in late stage R&D;
Trade mark issues associated with pharmaceuticals;
Post Authorisation;
Agreements for exploiting proven products, including co-marketing and co-promotion;
Regulatory issues post authorisation for pharmaceuticals, including pricing;
Regulatory issues post associated in other applications of biotechnology than pharmaceuticals;
Product liability;
Parallel Imports and Generic Competition;
Parallel imports;
Patents and generic competition;
Regulatory data protection and generic competition;